Green Cross Medico are delighted to announce we have appointed Aquilant as our UK distributor for Airglove our award winning innovation for IV access. Aquilant is a leading provider of specialist healthcare and scientific products and services, providing outsourced sales, marketing, distribution and engineering for the medical and scientific sectors. Now part of the Healthcare 21 Group of companies established in 2003, Healthcare 21 is one of Europe’s largest privately owned healthcare companies with operations across the UK, Germany, Austria and Ireland.
With the expertise and support they provide from their focused therapy team to healthcare professionals they will certainly make a noticeable difference with Airglove achieving the very best outcomes for patients. In trials at The Maidstone & Tunbridge Wells NHS Trust, Airglove achieved 87.5% success with 1st time cannulation in some of their most difficult to cannulate patients in oncology. With extended courses of treatment such as chemotherapy repeated cannulation is often required. Airglove can benefit damaged, hidden or fragile veins by gently warming up the local area in just 3-6 minutes raising the veins allowing for a much easier cannula insertion.
When Airglove was introduced and trialled at the West of Scotland PET Centre, Gartnavel Hospital Glasgow Mary Milligan, Imaging Services Manager said “It is proving to be very helpful we are gaining venous access quicker which helps with our timed injections. This means that our day is flowing more smoothly and it’s helping us to keep to appointment times. Therefore less extra waiting time for our patients. It is also allowing us to mostly cannulise rather than use butterfly’s. It takes longer to administer the radioactive isotope through butterfly’s. This means the dose of radiation the technical staff receive while doing this task is lower. This is always our aim to reduce our personal dose.”